Mcl-1 levels were found enhanced in MM cell lines in response to IL-6, following activation of the JAK/STAT3 pathway, and also in cell lines and primary cells in the presence of VEGF [219,220,221]. This evidence concerns the gene MCL1 and Miyoshi myopathy.